These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18607038)

  • 1. The Indian and Chinese health biotechnology industries: potential champions of global health?
    Frew SE; Kettler HE; Singer PA
    Health Aff (Millwood); 2008; 27(4):1029-41. PubMed ID: 18607038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hidden dragons.
    Zeng M; Williamson PJ
    Harv Bus Rev; 2003 Oct; 81(10):92-9, 137. PubMed ID: 14521101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. India's growing clinical research sector: opportunity for global companies.
    Varawalla N
    IDrugs; 2007 Jun; 10(6):391-4. PubMed ID: 17642002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indian Biotech Bazaar: a swot analysis.
    Kumar A
    Biotechnol J; 2007 May; 2(5):543-5. PubMed ID: 17479978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From maturity to value-added innovation: lessons from the pharmaceutical and agro-biotechnology industries.
    Mittra J; Tait J; Wield D
    Trends Biotechnol; 2011 Mar; 29(3):105-9. PubMed ID: 21163543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health in China and India: a cross-country comparison in a context of rapid globalisation.
    Dummer TJ; Cook IG
    Soc Sci Med; 2008 Aug; 67(4):590-605. PubMed ID: 18554766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building local research and development capacity for the prevention and cure of neglected diseases: the case of India.
    Kettler HE; Modi R
    Bull World Health Organ; 2001; 79(8):742-7. PubMed ID: 11545331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Past, present, and future industrial biotechnology in China.
    Li Z; Ji X; Kan S; Qiao H; Jiang M; Lu D; Wang J; Huang H; Jia H; Ouyuang P; Ying H
    Adv Biochem Eng Biotechnol; 2010; 122():1-42. PubMed ID: 20582527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 12. Should platform companies move toward products?
    Ratner M
    Nat Biotechnol; 1999 Jan; 17(1):16-7. PubMed ID: 9920255
    [No Abstract]   [Full Text] [Related]  

  • 13. Strategic considerations for the biotechnology business to the year 2000.
    Cometta S
    Arzneimittelforschung; 1989 Aug; 39(8):929-34. PubMed ID: 2818683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A business plan to help the 'global South' in its fight against neglected diseases.
    Frew SE; Liu VY; Singer PA
    Health Aff (Millwood); 2009; 28(6):1760-73. PubMed ID: 19887417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The search for new global health entrepeneurs.
    Keller HE
    Nat Rev Drug Discov; 2003 Nov; 2(11):931. PubMed ID: 14702952
    [No Abstract]   [Full Text] [Related]  

  • 16. Global Biotech goes China - Institut Pasteur Shanghai launches a unique platform for global biotech companies in China.
    Altmeyer R
    Biotechnol J; 2011 Nov; 6(11):1303-4. PubMed ID: 21438155
    [No Abstract]   [Full Text] [Related]  

  • 17. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

  • 18. [Future challenges and prospects for drug companies].
    Lajoux C
    Bull Acad Natl Med; 2008 Apr; 192(4):623-30; discussion 630-2. PubMed ID: 19024935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indian companies to watch in 2007.
    Biotechnol J; 2007 Mar; 2(3):293. PubMed ID: 17354216
    [No Abstract]   [Full Text] [Related]  

  • 20. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.